TARSUS PHARMACEUTICALS INC (TARS:NASDAQ)
$59.42 -0.12 (-0.2015%)
Analysed TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) News Sources
Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements
06-05-2026
yahoo.com
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Beats Revenue Estimates
06-05-2026
yahoo.com
Tarsus Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
07-05-2026
moby.co
Tarsus Pharmaceuticals Q1 Earnings Call Highlights
07-05-2026
marketbeat.com
Is It Time To Reassess Tarsus Pharmaceuticals (TARS) After Its Recent Share Price Swings?
11-05-2026
yahoo.com
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Share Price Weakness And Long Term Gains
12-05-2026
yahoo.com
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
14-05-2026
yahoo.com
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter
24-05-2026
fool.com
This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million
24-05-2026
fool.com
Tarsus to Participate in Upcoming Investor Conferences
28-05-2026
yahoo.com
What is the current price of TARSUS PHARMACEUTICALS INC (TARS:NASDAQ)?
The current price of TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) is $59.42.
TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) absolute price change since previous trading day?
The absolute price change of TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) since the previous trading day is $-0.12.
TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) percentage price change since previous trading day?
The percentage price change of TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) since the previous trading day is -0.2015%.
What is the most recent average sentiment score for TARSUS PHARMACEUTICALS INC (TARS:NASDAQ)?
The most recent average sentiment score for TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for TARSUS PHARMACEUTICALS INC (TARS:NASDAQ)?
The most recent sentiment for TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) is .
SEC-8K** Filing Available For TARSUS PHARMACEUTICALS INC (TARS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.